SCHEMBL8934579

SCHEMBL8934579

CN(S)C(=O)Nc1ccc(-c2cc3ccccc3oc2=O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.67
RAB9A P51151 8/20 0.67
SMN1; SMN2 Q16637 7/20 0.67
NPC1 O15118 7/20 0.67
KDM4E B2RXH2 6/20 0.67
MAPT P10636 4/20 0.57
HPGD P15428 4/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
NCOA1 Q15788 2/20 0.57
GLA P06280 1/20 0.57
PPARG P37231 1/20 0.57
NCOA2 Q15596 1/20 0.57
GAA P10253 2/20 0.57
GAPDH P04406 2/20 0.56
ESR1 P03372 1/20 0.56
ESR2 Q92731 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
TP53 P04637 1/20 0.55
MAOB P27338 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13757025 0.84 ALDH1A1 (0.75) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL8447062 0.80 ALDH1A1 (0.69) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL8934577 0.78 ALDH1A1 (0.68) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL13757026 0.78 ALDH1A1 (0.67) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL19003439 0.78 ALDH1A1 (0.69) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL14880355 0.75 ALDH1A1 (0.68) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL12010984 0.75 MAOB (0.63) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL15216064 0.75 ALDH1A1 (0.69) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL14880142 0.75 ALDH1A1 (0.69) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL12387899 0.75 ALDH1A1 (0.69) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed